FDA Intervenes With Anti-Diarrhea Drug Packaging

To encourage proper dosage, the FDA is working with manufacturers to use single dose packaging for anti-diarrhea drugs.

Imodium / Image: HealthDay
Imodium / Image: HealthDay

According to a recent FDA MedWatch article, the FDA has been inundated with reports of serious heart problems and deaths linked to people taking higher than recommended doses of loperamide. More commonly known as Imodium, loperamide is an anti-diarrhea medication that acts on opioid receptors in the intestines to decrease the number of bowel movements. Apparently consumers are intentionally taking much more than the recommended dosage.

The FDA’s maximum approved daily dose for adults is 8 mg per day, but when more is taken it can lead to heart rhythm issues or even death. To prevent this, the FDA is working with manufacturers to implement the use of blister packs and other single dose packaging to minimize the number of doses in each package.

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report